Carregant...
Engineered Micro- and Nanoparticles for Fibrinolysis
Fibrinolytic agents including plasmin and plasminogen activators improve outcomes in acute ischemic stroke and thrombosis by recanalizing occluded vessels. In the decades since their introduction into clinical practice, several limitations of have been identified both in terms of efficacy and bleedi...
Guardat en:
| Publicat a: | J Thromb Haemost |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6893081/ https://ncbi.nlm.nih.gov/pubmed/31529593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14637 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|